Bulletin Updates
Rossari’s debt rise forces ICRA to keep watching the capex story – 8 May 2026
May 08, 2026
ICRA has flagged Rossari Biotech’s higher debt and leverage after FY26 results.
The planned Rs 192 crore capex has been rescheduled and will now be phased over two years.
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »